Outcomes of recipients of both bone marrow and solid organ transplants: A review

Medicine

Volumn 77, Issue 5, 1998, Pages 355-369

  Dey, Bimalangshu ^a   Sykes, Megan ^a   Spitzer, Thomas R ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BONE MARROW TRANSPLANTATION; CELL SURVIVAL; GRAFT VERSUS HOST REACTION; HEART FAILURE; HIGH RISK POPULATION; HUMAN; KIDNEY FAILURE; LIVER FAILURE; LUNG INSUFFICIENCY; ORGAN TRANSPLANTATION; OUTCOMES RESEARCH; PRIORITY JOURNAL; RECIPIENT; REVIEW;

BONE MARROW TRANSPLANTATION; CARDIOMYOPATHIES; GRAFT VS HOST DISEASE; HUMANS; IMMUNE TOLERANCE; KIDNEY FAILURE, CHRONIC; LIVER FAILURE; LUNG DISEASES; ORGAN TRANSPLANTATION; TRANSPLANTATION IMMUNOLOGY; TREATMENT OUTCOME;

EID: 0031658155     PISSN: 00257974     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005792-199809000-00005     Document Type: Review

References (107)

1. Alter BP. The bone marrow failure syndromes. In: Nathan DG, Oski FA, eds. Hematology of infancy and childhood. 3rd ed. Philadelphia: Saunders. pp 159-241, 1987.
2. Antignac C, Gubler MC, Leverger G, Broyer M, Habib R. Delayed renal failure with extensive mesangiolysis following bone marrow transplantation. Kidney Int 35: 1336-44, 1989.
3. Attal M, Huguet F, Rubie H, Huynh A, Charlet JP, Payen JL, Voigt JJ, Brousset P, Selves J, Muller C, et al. Prevention of hepatic veno-occlusive disease after bone marrow transplantation by continuous infusion of low-dose heparin A prospective, randomized trial. Blood 79: 2834-40, 1992.
4. Barber WH, Mankin JA, Laskow DA, Deierhoi MH, Julian BA, Curtis JJ, Diethelm AG. Long-term results of a controlled prospective study with transfusion of donor-specific bone marrow in 57 cadaveric renal allograft recipients. Transplantation 51: 70-75, 1991.
5. Bass EB, Powe NR, Goodman SN, Graziano SL, Griffiths RI, Wingard JR, et al. Efficacy of intravenous immune globulin in preventing complications of BMT: A meta-analysis. Bone Marrow Transplant 12: 273-82, 1993.
6. Bearman SI, Anderson GL, Mori M, Hinds MS, Shulman HM, McDonald GB. Veno-occlusive disease of the liver: Development of a model for predicting fatal outcome after marrow transplantation. J Clin Oncol 11: 1729-36, 1993.
7. Bearman SI, Shuhart MC, Hind MS, McDonald GB. Recombinant human tissue plasminogen activator for the treatment of established severe VOD of the liver after BMT. Blood 80: 2458-62, 1992.
8. Bearman SI. The syndrome of hepatic veno-occlusive disease after marrow transplantation. Blood 85: 3005-20, 1995.
9. Bergstein J, Andreoli SP, Provisor AJ, Yum M. Radiation nephritis following total-body irradiation and cyclophosphamide in preparation for bone marrow transplantation. Transplantation 41: 63-66, 1986.
10. Billingham RE, Brent L, Medawar PB. Actively acquired tolerance of foreign cells. Nature 172: 603-6, 1953.
11. Bismuth H, Samuel D, Gugenheim J, Castaing D, Bernuau J, Rueff B, Benhamou J. Emergency liver transplantation for fulminant hepatitis. Ann Intern Med 107: 337-41, 1987.
12. Boas SR, Noyes BE, Armitage J, Orenstein D. Pediatric lung transplantation for GVHD following BMT. Chest 105: 1584-86, 1994.
13. Bowden RA, Slichter SJ, Sayers MH, Mori M, Cays MJ, Meyers JD. Use of leukocyte-depleted platelets and cytomegalovirus-seronegative red blood cells for prevention of primary CMV infection after marrow transplant. Blood 78: 246-50, 1991.
14. Braun WE. Molecular, genetic and clinical aspects of the HLA system. In: Cerilli GJ, ed. Organ transplantation and replacement. Philadelphia: JB Lippincott, pp 162-95, 1988.
15. Bunin N, Leahey A, Dunn S. Related donor liver transplant for VOD following T-cell depleted unrelated donor BMT. Transplantation 61: 664-66, 1996.
16. Calhoon JH, Levine S, Anzueto A, Bryan CL, Trinkle JK. Lung transplantation in a patient with prior bone marrow transplant. Chest 102: 948, 1992.
17. Camitta BM, Nathan DG, Forman EN, Parkman R, Rappaport JM, Orellana TD. Posthepatitic severe aplastic anemia - an indication for early bone marrow transplantation. Blood 43: 473-83, 1974.
18. Camitta BM, Storb R, Thomas ED. Aplastic anemia: Pathogenesis, diagnosis, treatment, and prognosis. N Engl J Med 306: 645-52 (Part 1), 712-18 (Part 2), 1982.
19. Chan CK, Hyland RH, Hutcheon MA. Pulmonary complications following bone marrow transplantation. Clin Chest Med 11: 323-32, 1990.
20. Charlton B, Auchincloss H Jr, Fathman CG. Mechanisms of transplantation tolerance. Annu Rev Immunol 12: 707-34, 1994.
21. Clark SC, Kamen R. The human hematopoietic colony stimulating factors. Science 236: 1229-37, 1987.
22. Coluhoun SD, Shaked A, Jurim O, Colonna JO, Rosove MH, Busuttil RW. Reversal of neutropenia with granulocyte colony stimulating factor without precipitating liver allograft rejection. Transplantation 56: 1593-95, 1993.
23. Deeg HJ, Storb R. Acute and chronic GVHD: Clinical manifestations, prophylaxis, and treatment. JNCI 76: 1325-28, 1986.
24. Dienstag JL. Non-A, non-B hepatitis. I. Recognition, epidemiology, and clinical features. Gastroenterology 85: 439-62, 1983.
25. Dowlati A, Honore P, Fillet G, Beguin Y. Hepatic rejection after orthotopic liver transplantation for hepatic VOD or GVHD following BMT. Transplantation 60: 106-9, 1995.
26. Dugan J, Rouch DA, Akard LP, Sperl BG, Black JR, Markham RE Jr. Successful allogeneic bone marrow transplantation in an adult with aplastic anemia following orthotopic liver transplantation for non-A, non-B, non-C hepatitis. Bone Marrow Transplantation 12: 417-19, 1993.
27. Gluckman E, Jolivet I, Scrobohaci ML, Devergie A, Traineau R, Bourdeau-Esperou H, Lehn P, Faure P, Drouet L. Use of prostaglandin E1 for prevention of liver veno-occlusive disease in leukaemic patients treated by allogeneic bone marrow transplantation. Br J Haematol 74: 277-81, 1990.
28. Goldberg MA, Antin JH, Guinan EC, Rappeport JM. Cyclophosphamide cardiotoxicity: An analysis of dosing as a risk factor. Blood 68: 1114-18, 1986.
29. Gottdiener JS, Appelbaum FR, Ferrans VJ, Deisseroth A, Ziegler J. Cardiotoxicity associated with high-dose cyclophosphamide therapy. Arch Intern Med 141: 758-63, 1981.
30. Hackman RC, Madtes DK, Petersen FB. Pulmonary veno-occlusive disease following bone marrow transplantation. Transplantation 47: 989-92, 1989.
31. Hagler L, Pastore RA, Bergin JJ, Wrensch MR. Aplastic anemia following viral hepatitis. Medicine (Baltimore) 54: 139-64, 1975.
32. Helf C, Chapuis B, Bolle JF, Jeannet M, Leski M. Renal transplantation without immunosuppression in a host with tolerance induced by allogeneic BMT. Transplantation 58: 1420-22, 1994.
33. Hill RS, Petersen FB, Storb R, Appelbaum FR, Doney K, Dahlberg S, Ramberg R, Thomas ED. Mixed hematologic chimerism after allogeneic marrow transplantation for severe aplastic anemia is associated with a higher risk of graft rejection and a lessened incidence of acute graft-versus-host disease. Blood 67: 811-16, 1986.
34. Ildstad ST, Sachs DH. Reconstitution with syngeneic plus allogeneic or xenogeneic bone marrow leads to specific acceptance of allografts or xenografts. Nature 307: 168-170, 1984.
35. Ildstad ST, Wren SM, Boggs SS, Hronakes ML, Vecchini F, Van den Brink MRM. Cross-species bone marrow transplantation: Evidence for tolerance induction, stem cell engraftment, and maturation of T lymphocytes in a xenogeneic stromal environment (rat→mouse). J Exp Med 174: 467-78, 1991.
36. International Bone Marrow Transplant Registry (IBMTR) correspondence. Statistical Center, Medical College of Wisconsin, Milwaukee, WI 53226. February 17, 1995.
37. Jacobsen N, Taaning E, Ladefoged J, Pedersen FK. Tolerance to an HIA-B, DR disparate kidney allograft after BMT from same donor. Lancet 343: 800, 1994.
38. Jamieson NV, Joysey V, Friend PJ, Marcus R, Ramsbottom S, Baglin T, Johnston PS, Williams R, Calne RY. Graft-versus-host disease in solid organ transplantation. Transplant Int 4: 67-71, 1991.
39. Juckett M, Perry EH, Daniels BS, Weisdorf DJ. Hemolytic uremic syndrome following bone marrow transplantation. Bone Marrow Transplant 7: 405-9, 1991.
40. Kanj SS, Sharara AI, Shpall EJ, Jones RB, Peters WP. Myocardial ischemia associated with high-dose carmustine infusion. Cancer 68: 1910-12, 1991.
41. Kawahara K, Storb R, Sanders J, Petersen FB. Successful allogeneic BMT in a 6.5-year-old male for severe aplastic anemia complicating orthotopic liver transplantation for fulminant non-A, non-B hepatitis. Blood 78: 1140-43, 1991.
42. Kawai T, Cosimi AB, Colvin RB, Powelson J, Eason J, Kozlowski T, Sykes M, Monroy R, Tanaka M, Sachs DH. Mixed allogeneic chimerism and renal allograft tolerance in cynomologous monkeys. Transplantation 59: 256-62, 1995.
43. Kimball P, Ham J, Eisenberg M, King A, Fisher R, Rhodes C, Posner M. Lethal graft-versus-host disease after simultaneous kidney-pancreas transplantation. Transplantation 63: 1685-88, 1997.
44. Knapp AB, Crawford JM, Rappaport JM, Gollan JL. Cirrhosis as a consequence of GVHD. Gastroenterology 92: 513-19, 1987.
45. Krowka MJ, Rosenow EC, Hoagland HC. Pulmonary complications of bone marrow transplantation. Chest 87: 237-46, 1985.
46. Lipshultz SE, Colan SD, Gelber RD, Perez-Atayde AR, Sallan SE, Sanders SP. Late cardiac effects of doxorubicin therapy for acute lymphoblastic leukemia in childhood. N Engl J Med 324: 808-15, 1991.
47. Mackinnon S, Barnett L, Bourhis JH, Black P, Heller G, O'Reilly RJ. Myeloid and lymphoid chimerism after T-cell-depleted bone marrow transplantation: Evaluation of conditioning regimens using the PCR to amplify human minisatellite regions of genomic DNA. Blood 80: 3235-41, 1992.
48. Mahe B, Moreau P, Le Tortorec M, Hourmant M, Milpied N. Autologous bone marrow transplantation for cyclosporine-related lymphoma in a renal transplant patient. Bone Marrow Transplant 14: 645-46, 1994.
49. Main JM, Prehn RT. Successful skin homografts after administration of high dose irradiation and homologous bone marrow. J Natl Cancer Inst 15: 1023-29, 1955.
50. Marks DI, Dousset B, Robson A, Imvrios G, Batchelor R, Goldman JM. Orthotopic liver transplantation for hepatic GVHD following allogeneic BMT for chronic myeloid leukemia. Bone Marrow Transplant 10: 463-66, 1992.
51. McDonald GB, Hinds MS, Fisher LD, Schoch HG, Wolford JL, Banaji M, Hardin BJ, Shulman HM, Clift RA. Veno-occlusive disease of the liver and multiorgan failure after bone marrow transplantation: A cohort study of 355 patients. Ann Intern Med 118: 255-67, 1993.
52. McDonald GB, Sharma PK, Matthews DE, Shulman HM, Thomas ED. Veno-occlusive disease of the liver after BMT: Diagnosis, incidence, and predisposing factors. Hepatology 4: 116-22, 1984.
53. McDonald GB, Shulman HM, Wolford JL, Spencer GD. Liver disease after human marrow transplantation. Semin Liver Dis 7: 210-29, 1987.
54. McDonald GB. Liver disease after bone marrow transplantation. In: Hoofnagle JH, Goodman Z, eds. Liver biopsy interpretation for the 1990's. Clinicopathologic correlations in liver disease. Thorofare, NJ: American Association for the Study of Liver Diseases, pp 841-53, 1991.
55. Meyers JD, Reed EC, Shepp DH, Thomquist M, Dandliker PS, Vicary CA, Floumoy N, Kirk LE, Kersey JH, Thomas ED, et al. Acyclovir for prevention of cytomegalovirus infection and disease after allogeneic marrow transplantation. N Engl J Med 318: 70-75, 1988.
56. Mitchison NA. The colonization of irradiated tissue by transplanted spleen cells. Br J Exp Pathol 37: 239-47, 1956.
57. Nimer SD, Milewicz AL, Champlin RE, Busuttil RW. Successful treatment of hepatic veno-occlusive disease in a bone marrow transplant patient with orthotopic liver transplantation. Transplantation 49: 819-821, 1990.
58. Popitz-Bergez FA, Sakamoto K, Pennington LR, Pescovitz MD, McDonough MA, MacVittie TJ, Gress RE, Sachs DH. Bone marrow transplantation in miniature swine. II. Effect of selective genetic differences on marrow engraftment and recipient survival. Transplantation 45: 27-31, 1988.
59. Powles RL, Clink HM, Spence D, Morgenstern G, Watson JG, Selby PJ, Woods M, Barrett A, Jameson B, Sloane J, Lawler SD, Kay HE, Lawson D, McElwain TJ, Alexander P. Cyclosporine A to prevent graft-versus-host disease in man after allogeneic bone-marrow transplantation. Lancet 1: 327-29, 1980.
60. Ramrakha PS, Marks DI, O'Brien SG, Schofield JB, Goldman JM. Orthotopic cardiac transplantation for dilated cardiomyopathy after allogeneic BMT. Clin Transplant 8: 23-26, 1994.
61. Rapoport AP, Doyle HR, Starzl T, Rowe JM, DiPersio JF. Orthotopic liver transplantation for life-threatening veno-occlusive disease of the liver after allogeneic bone marrow transplantation. Bone Marrow Transplant 8: 421-24, 1991.
62. Rhodes DF, Lee WM, Wingard JR, Sorrell MF, Markin RS. Orthotopic liver transplantation for graft-vs-host disease following bone marrow transplantation. Gastroenterology 99: 536-38, 1990.
63. Richter N, Raddatz G, Graeter T, Schafers HJ, Schlitt HJ. Allogeneic lymphocyte chimerism after clinical lung transplantation. Transplant Immunol 3: 74-80, 1995.
64. Ricordi C, Karatzas T, Nery J, Webb M, Selvaggi G, Fernandez L, Khan FA, Ruiz P, Schiff E, Olson L, Fernandez H, Bean J, Esquenazi V, Miller J, Tzakis AG. High-dose donor bone marrow infusions to enhance allograft survival: The effect of timing. Transplantation 63: 7-11, 1997.
65. Ringden O, Wennberg L, Ericzon BG, Kallman R, Astrom M, Duraj F, Soderdahl G, Tyden G, Groth CG. Alteplase for hepatic veno-occlusive disease after bone marrow transplantation [letter]. Lancet 340: 546-47, 1992.
66. Roberts JP, Ascher NL, Lake J, Capper J, Purohit S, Garovoy M, Lynch R, Ferrell L, Wright T. Graft-versus-host disease after liver transplantation in humans: A report of four cases. Hepatology 14: 274-81, 1991.
67. Rosen HR, Martin P, Schiller GJ, Territo M, Lewin DN, Shackleton CR, Busuttil RW. Orthotopic liver transplantation for bone marrow transplant-associated veno-occlusive disease and graft-versus-host disease of the liver. Liver Transplant Surg 2: 225-32, 1996.
68. Roux E, Helg C, Chapuis B, Jeannet M, Roosnek E. Evolution of mixed chimerism after allogeneic bone marrow transplantation as determined on granulocytes and mononuclear cells by the polymerase chain reaction. Blood 79: 2775-83, 1992.
69. Sayegh MH, Fine NA, Milford EL, Tilney NL. Immunologic tolerance to renal allografts after bone marrow transplants from same donors. Ann Intern Med 114: 954-55, 1991.
70. Schlitt HJ, Raddatz G, Steinhoff G, Wonigeit K, Pichlmayr R. Passenger lymphocytes in human liver allografts and their potential role after transplantation. Transplantation 56: 1001-7, 1993.
71. Schlitt HJ, Tischler HJ, Ringe B, Raddatz G, Kuse E, Pichlmayr R. Allogeneic liver transplantation for hepatic VOD after BMT - clinical and immunological considerations. Bone Marrow Transplant 16: 473-78, 1995.
72. Sharabi Y, Abraham VS, Sykes M, Sachs DH. Mixed allogeneic chimeras prepared by a non-myeloablative regimen: Requirement for chimerism to maintain tolerance. Bone Marrow Transplant 9: 191-97, 1992.
73. Sharabi Y, Sachs DH. Mixed chimerism and permanent specific transplantation tolerance induced by a non-lethal preparative regimen. J Exp Med 169: 493-502, 1989.
74. Shulman HM, Fisher LB, Schoch HG, Henne KW, McDonald GB. Veno-occlusive disease of the liver after BMT: Histological correlates of clinical signs and symptoms. Hepatology 19: 1171-80, 1994.
75. Slavin S, Strober S, Fuks Z, Kaplan HS. Long-term survival of skin allografts in mice treated with fractionated total lymphoid irradiation. Science 193: 1252, 1976.
76. Sorof JM, Koerper MA, DeSantes K, Cowan M. Renal transplantation without chronic immunosuppression after T-cell-depleted, HLA-mismatched bone marrow transplantation. Transplantation 59: 1633-35, 1995.
77. Souza LM, Boone TC. Gabrilove J, Lai PH, Zsebo KM, Murdock DC, Chazin VR, Bruszewski J, Lu H, Chen KK, et al. Recombinant human granulocyte colony-stimulating factor: Effects on normal and leukemic myeloid cells. Science 232: 61-65, 1986.
78. Spitzer TR, Himoe E, Cottler-Fox M, Cahill R, Deeg HJ. Long-term stable mixed chimerism following allogeneic marrow transplantation for severe aplastic anemia. Br J Haematol 76: 146-54, 1990.
79. Spitzer TR, Zwiebel J. Jacobson RJ. Transplants from the same donor. Ann Intern Med 115: 498, 1991.
80. Starzl TE. Cell migration and chimerism - a unifying concept in transplantation - with particular reference to HLA matching and tolerance induction. Transplant Proc 25: 8-12, 1993.
81. Starzl TE, Demetris AJ, Murase N, Udstad ST, Ricordi C, Trucco M. Cell migration, chimerism, and graft acceptance. Lancet 339: 1579-82, 1992.
82. Starzl TE, Demetris AJ, Trucco M, Murase N, Ricordi C, Ildstad S, Ramos H, Todo S, Tzakis A, Fung JJ, et al*. Cell migration and chimerism after whole organ transplantation: The basis of graft acceptance. Hepatology 17: 1127-52, 1993.
83. Starzl TE, Demetris AJ, Trucco M, Ramos H, Zeevi A, Rudert WA, Kocova M, Ricordi C, Ildstad S, Murase N. Systemic chimerism in human female recipients of male livers. Lancet 340: 876-77, 1992.
84. Starzl TE, Demetris AJ, Trucco M, Zeevi A, Ramos H, Terasaki P, Rudert WA, Kocova M, Ildstad S, et al. Chimerism and donor-specific non-reactivity 27 to 29 years after kidney allotransplantation. Transplantation 55: 1272-77, 1993.
85. Storb R, Deeg HJ, Pepe M, Appelbaum F, Anasetti C, Clift R, et al. Methotrexate and cyclosporine versus cyclosporine alone for prophylaxis of GVHD in patients given HLA-identical marrow grafts for leukemia: Long-term follow-up of a controlled trial. Blood 73: 1729-34, 1989.
86. Storb R, Deeg HJ, Whitehead J, Appelbaum F, Beatty P, Bensinger W, Buckner CD, Clift R, Doney K, Farewell V, et al. Methotrexate and cyclosporine compared with cyclosporine alone for prophylaxis of acute graft versus host disease after marrow transplantation for leukemia. N Engl J Med 314: 729-35, 1986.
87. Storb R, Thomas ED. Allogeneic marrow transplantation for aplastic anemia. In: Champlin RE, Gale RP, eds. New strategies in bone marrow transplantation, UCLA symposia on molecular and cellular biology, New Series vol. 137. New York: Wiley-Liss, p 73, 1991.
88. Sullivan KM, Agura E, Anasetti C, Appelbaum F, Badger C, Bearman S, Erickson K, Flowers M, Hansen J, Loughran T, Martin P, Matthews D, Petersdorf E, Radich J, Riddell S, Rovira D, Sanders J, Scheuring F, Siadak M, Storb R, Witherspoon RP. Chronic graft-versus-host disease and other late complications of bone marrow transplantation. Semin Hematol 28: 250-59, 1991.
89. Sullivan KM, Witherspoon RP, Storb R, et al. Alternating-day cyclosporine and prednisone for treatment of high-risk chronic graft-v-host disease. Blood 72: 555-61, 1988.
90. Sullivan KM. Graft-versus-host disease In: Forman SJ, Blume KG, Thomas ED, eds. Bone marrow transplantation. Oxford: Blackwell Scientific, pp 339-62, 1994.
91. Svendsen U. Aggestrup S, Heilmann C, Jacobsen N, Svejgaard A, Thisted B. Transplantation of a lobe of lung from mother to child following previous transplantation with maternal bone marrow. Transplant Proc 27: 3483-84, 1995.
92. Sykes M, Sachs DH, Pearson DA, Moulton AD, Bodine DM. Specific prolongation of skin graft survival following retroviral transduction of bone marrow with an allogeneic major histocompatibility complex gene. Transplantation 55: 197-202, 1993.
93. Sykes M, Sharabi Y, Sachs DH. Achieving alloengraftment without graft-versus-host disease: Approaches using mixed allogeneic bone marrow transplantation. Bone Marrow Transplant 3: 379-86, 1988.
94. Sykes M, Szot GL, Swenson KA, Pearson DA. Induction of high levels of allogeneic hematopoietic reconstitution and donor-specific tolerance without myelosuppressive conditioning. Nat Med 3: 783-87, 1997.
95. Sykes M. Chimerism and central tolerance. Curr Opin Immunol 8: 694-703, 1996.
96. Tarbell NJ, Guinan EC, Chin L, Mauch P, Weinstein SJ. Renal insufficiency after total-body irradiation for pediatric bone marrow transplantation. Radiother Oncol 18(Suppl 1): 139-42, 1990.
97. Tarbell NJ, Guinan EC, Niemeyer C, Mauch P, Sallan SE, Weinstein HJ. Late onset of renal dysfunction in survivors of BMT. Int J Radiat Oncol Biol Phys 15: 99-104, 1988.
98. Tomita Y, Khan A, Sykes M. Role of intrathymic clonal deletion and peripheral anergy in transplantation tolerance induced by bone marrow transplantation in mice conditioned with a non-myeloablative regimen. J Immunol 153: 1087-98, 1994.
99. Trede NS, Warwick AB, Rosoff PM, Rohrer R, Bierer BE, Guinan E. Tacrolimus (FK506) in allogeneic bone marrow transplantation for severe aplastic anemia following orthotopic liver transplantation. Bone Marrow Transplant 20: 257-60, 1997.
100. Tutschka PJ, Beschorner WE, Hess AD, Santos GW. Cyclosporine A to prevent GVHD: A pilot study in 22 patients receiving allogeneic marrow transplants. Blood 61: 318-25, 1983.
101. Tzakis AG, Arditi M, Whitington PF, Yanaga K, Esquivel C, Stock PG, et al. Aplastic anemia complicating orthotopic liver transplantation for non-A, non-B hepatitis. N Engl J Med 319: 393-96, 1988.
102. Vesole DH, Jagannath S. Transplants from the same donor. Ann Intern Med 116: 269-70, 1992.
103. Vogelsang GB, Hess AD, Santos GW. Acute graft-versus-host disease: Clinical characteristics in the cyclosporine era. Medicine (Baltimore) 67: 163-74, 1988.
104. Weekly clinicopathological exercise. Case records of the Massachusetts General Hospital. N Engl J Med 334: 1655-62, 1996.
105. Welte K, Bonilla MA, Gillio AP, Boone TC, Potter GK, Gabrilove JL, Moore MA, O'Reilly RJ, Souza LM. Recombinant human granulocyte colony-stimulating factor. Effects on hematopoiesis in normal and cyclophosphamide-treated primates. J Exp Med 165: 941-18, 1987.
106. Yau JC, Zander AR, Srigley JR, Verm RA, Stroehlein JR, Korinek JK, Vellekoop L, Dicke KA. Chronic graft-versus-host disease complicated by micronodular cirrhosis and esophageal varices. Transplantation 41: 129-30, 1986.
107. Zager RA, O'Quigley J, Zager BK, Alpers CE, Shulman HM, Gamelin LM, Stewart P, Thomas ED. Acute renal failure following bone marrow transplantation: A retrospective study of 272 patients. Am J Kidney Dis 13: 210-16, 1989.